Indaptus Therapeutics Stock Forecast

Sell candidate since Jun 03, 2026

The Indaptus Therapeutics, Inc. stock price gained 2.79% on the last trading day (Wednesday, 3rd Jun 2026), rising from $2.15 to $2.21. It has now gained 6 days in a row. It is not often that stocks manage to gain so many days in a row, and falls for a day or two should be expected. During the last trading day the stock fluctuated 13.79% from a day low at $2.03 to a day high of $2.31. The price has risen in 7 of the last 10 days and is up by 66.17% over the past 2 weeks. Volume fell on the last day by -8 thousand shares and in total, 98 thousand shares were bought and sold for approximately $216.39 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock is moving within a very wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect Indaptus Therapeutics, Inc. stock with a 90% probability to be traded between $1.03 and $3.51 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

INDP Signals & Forecast

A buy signal was issued from a pivot bottom point on Thursday, May 21, 2026, and so far it has risen 108.49%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Indaptus Therapeutics, Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $2.22. On a fall, the stock will find some support from the short-term average at $1.69. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.

Support, Risk & Stop-loss for Indaptus Therapeutics, Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $2.09 and $1.76. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Indaptus Therapeutics, Inc. finds support just below today's level at $2.09. If this is broken, then the next support from accumulated volume will be at $1.76 and $1.75.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.280 between high and low, or 13.79%. For the last week the stock has had daily average volatility of 21.06%.

Since the Indaptus Therapeutics, Inc. has been rising for 6 days in a row, the risk over the next couple of days has increased.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (INDP) For The Upcoming Trading Day Of Thursday 4th

For the upcoming trading day on Thursday, 4th we expect Indaptus Therapeutics, Inc. to open at $2.18, and during the day (based on 14 day Average True Range), to move between $2.07 and $2.35, which gives a possible trading interval of +/-$0.273 (+/-13.14%) up or down from last closing price. If Indaptus Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 13.14% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $2.33 (5.43%) than the support at $2.09 (5.43%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Indaptus Therapeutics, Inc. stock A Buy?

Indaptus Therapeutics, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.

Current score: -1.354 Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on June 4, 2026 - $2.18 ( 1.21%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk